Department of Medicine 5 – Haematology and Oncology

Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy (2024) Lischer C, Eberhardt M, Flamann C, Berges J, Güse E, Wessely A, Weich A, et al. Journal article CAR T-Cell Therapy in Autoimmune Disease. Reply. (2024) Müller F, Mackensen A, Schett G Journal article, Letter TaKeTiNa Music Therapy for Outpatient Treatment of Depression: Study Protocol for a Randomized Clinical Trial (2024) Behzad A, Feldmann-Schulz C, Lenz B, Clarkson L, Ludwig C, Luttenberger K, Völkl S, et al. Journal article Adaptive immune responses are larger and functionally preserved in a hypervaccinated individual (2024) Kocher K, Moosmann C, Drost F, Schülein C, Irrgang P, Steininger P, Zhong J, et al. Journal article CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis (2024) Krickau T, Naumann-Bartsch N, Aigner M, Kharboutli S, Kretschmann S, Spörl S, Vasova I, et al. Journal article Treg depletion supercharges ASCT power (2024) Bruns H Journal article Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2024) Maffini E, Labopin M, Kröger N, Finke J, Stelljes M, Schroeder T, Einsele H, et al. Journal article Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia (2024) Burmeister T, Ströh AS, Kehden B, Trautmann H, Meyer C, Marschalek R, Larghero P, et al. Journal article, Letter Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries (2024) Lübke J, Christen D, Schwaab J, Kaiser A, Naumann N, Shoumariyeh K, Jentzsch M, et al. Journal article Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. (2024) Gagelmann N, Dima D, Merz M, Hashmi H, Ahmed N, Tovar N, Oliver-Caldés A, et al. Journal article